- Home
- SGML vs DAWN Comparison
SGML vs DAWN Comparison
Compare SGML & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SGML | DAWN |
|---|---|---|
| Founded | 2011 | 2018 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.2B |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SGML | DAWN |
|---|---|---|
| Price | $19.50 | $21.52 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 8 |
| Target Price | $18.75 | ★ $24.43 |
| AVG Volume (30 Days) | ★ 5.0M | 1.5M |
| Earning Date | 05-13-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $158,182,000.00 |
| Revenue This Year | $272.11 | $55.03 |
| Revenue Next Year | $36.70 | $28.12 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 20.60 |
| 52 Week Low | $4.25 | $5.64 |
| 52 Week High | $22.32 | $21.53 |
Technical Indicators
Market Signals| Indicator | SGML | DAWN |
|---|---|---|
| Relative Strength Index (RSI) | 63.25 | 80.29 |
| Support Level | $10.00 | $10.30 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 1.49 | 0.03 |
| MACD | 0.37 | -0.28 |
| Stochastic Oscillator | 68.77 | 90.91 |
Price Performance
Historical ComparisonAbout SGML Sigma Lithium Corporation
Sigma Lithium Corp together with its direct and indirect subsidiaries, is a commercial producer of lithium concentrate. It holds full interest in four mineral properties: Grota do Cirilo, Sao Jose, Santa Clara, and Genipapo, located in the municipalities of Aracuai and Itinga, in the Vale do Jequitinhonha region in the State of Minas Gerais, Brazil. Geographically, the company operates in Switzerland; United Arab Emirates; Singapore; and Republic of Korea, of which it derives maximum revenue from Switzerland.
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY301 is an antibody drug conjugate (ADC) that has shown antitumor activity in preclinical models.